Paper Information

Journal:   DARU JOURNAL OF PHARMACEUTICAL SCIENCE   2004 , Volume 12 , Number 3; Page(s) 123 To 130.
 
Paper: 

INFLUENCE OF FORMULATION VARIABLES AND INHALATION DEVICE ON THE DEPOSITION PROFILES OF CROMOLYN SODIUM DRY POWDER AEROSOLS

 
 
Author(s):  GILANI K., ROUH ALAMINI NAJAFABADI A.A.H., DARABI M., BARGHI M.A., RAFIEI TEHRANI M.
 
* 
 
Abstract: 
Dry powder inhalers (DPIs) have attained considerable attention due to their propellant-free formulations and the patient’s inherent coordination with actuation. Generally, DPI formulations consist of a micronized drug alone or mixed with carrier particles. This study was carried out to investigate the effects of carrier particle size and weight fraction on aerosolisation behaviour of cromolyn sodium (CS). Pharmatose® 450M and Pharmatose® 325M, two commercial α-lactose monohydrate with different particle sizes, were blended in two different fractions (30 and 50% w/w) with CS. A low resistance device (Spinhaler®) and a medium resistance device (Cyclohaler®), were used to evaluate the effect of inhaler design on the deposition profiles of CS.
The in vitro deposition of the formulations was determined using a twin stage impinger (TSI). Fine particle dose, fine particle fraction and emitted dose of the drug were depended to both formulation and inhalation devices. Fine particle fractions of the drug aerosolised from the formulations ranged from 9.35 up to 36.45%. The highest fine particle fraction was produced by formulation containing 50% Pharmatose® 450M as carrier. Cyclohaler® showed higher efficiency in aerosolisation of CS compared to Spinhaler®.
 
Keyword(s): DRY POWDER INHALER , CROMOLYN SODIUM , LACTOSE , PARTICLE SIZE , WEIGHT FRACTION RATIO
 
References: 
 
  pdf-File tarjomyar Yearly Visit 75
 
Latest on Blog
Enter SID Blog